Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02442843 · ClinicalTrials.gov registry record · Early Phase 1

Non Invasive Brain Stimulation for PTSD

A Early Phase 1 study, sponsored by University of Michigan.

Completed
Registry status
Early Phase 1
Development phase
18
Enrollment target

NCT02442843 is a Early Phase 1 study that has completed, run by University of Michigan. The registered enrollment target is 18 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02442843, a Early Phase 1 study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
Early Phase 1
Development phase
18 participants
Enrollment target

Study Summary

This study is designed to identify changes in the brain that underlie symptoms of combat-related PTSD using brain imaging (fMRI). Then, the investigators will administer mild electrical stimulation to the side of the head (using a method called tDCS) in an attempt to reduce the symptoms of PTSD.

Interventions

  • DEVICE Sham tDCS
  • DEVICE Active tDCS

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2015-05
Est. Completion 2017-08-01
Phase Early Phase 1

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT02442843

The ClinicalTrials.gov registry entry for NCT02442843 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Sham tDCS is the first listed.

NCT02442843 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02442843 about?

NCT02442843 is a clinical study titled "Non Invasive Brain Stimulation for PTSD". This study is designed to identify changes in the brain that underlie symptoms of combat-related PTSD using brain imaging (fMRI). Then, the investigators will administer mild electrical stimulation to the side of the head (using a method called tDCS) in an attempt to reduce the symptoms of PTSD.

What is the current status of trial NCT02442843?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 18 participants. The study started on 2015-05. Estimated completion is 2017-08-01.

What interventions are being tested in trial NCT02442843?

The interventions under investigation include: Sham tDCS (DEVICE), Active tDCS (DEVICE).

Who is sponsoring clinical trial NCT02442843?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.